---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-019813"
form_type: "8-K"
ticker: "NNVC"
cik: "0001379006"
company_name: "NANOVIRICIDES, INC."
filed_at: "2023-02-13T23:59:59+00:00"
generated_at: "2026-06-19T15:46:48.192162+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# NanoViricides shareholders approve redomicile from Nevada to Delaware

## Summary
- On Feb 7, 2023, shareholders voted to reincorporate in Delaware from Nevada.
- Votes: 8,115,210 for, 942,379 against; 56% of outstanding voting capital present.
- Redomicile proposal was detailed in the Nov 15, 2022 proxy statement.
- Series A Convertible Preferred and common stock both entitled to vote.

## SEC filing metadata
- accession: 0001104659-23-019813
- form_type: 8-K
- ticker: NNVC
- cik: 0001379006
- company_name: NANOVIRICIDES, INC.
- filed_at: 2023-02-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1379006/000110465923019813/0001104659-23-019813-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1379006/000110465923019813/tm236570d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-019813
- JSON: https://secwatch.observer/filing/0001104659-23-019813.json
- Plain text: https://secwatch.observer/filing/0001104659-23-019813.txt

## Key facts
- Shareholder Votes
  NANOVIRICIDES, INC. shareholders approved The Redomicile of the Company as a Delaware Corporation at the 2023-02-07 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-02-07
  source text: Proposal 1 – The Redomicile of the Company as a Delaware Corporation: Votes For Votes Against/Withheld 8,115,210 942,379
  evidence_url: https://www.sec.gov/Archives/edgar/data/1379006/000110465923019813/0001104659-23-019813-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.